In this post for The JAMA Forum, the Kaiser Family Foundation’s Larry Levitt discusses the concept of allowing insurers to sell health plans across state lines and how such a proposal could affect people with pre-existing conditions.
- view as grid
- view as list
This column was published as a Wall Street Journal Think Tank column on October 12, 2016. U.S. Uninsured Rate is At An All-Time Low, But The Public Doesn’t Know It Donald Trump derided the Affordable Care Act in the second presidential debate as a “total disaster.” One inarguable success…
The leading US presidential candidates and their parties’ platforms offer distinct and often opposing policy proposals on issues that affect women’s health. In the Women’s Health Issues journal, the Kaiser Family Foundation’s Caroline Rosenzweig, Usha Ranji, and Alina Salganicoff present their analysis of the differences between the Democratic and Republican parties on range of women’s health policy issues – including the Affordable Care Act, reproductive health, older women’s health, and violence prevention.
In this Wall Street Journal Think Tank column, Drew Altman uses findings from a new KFF/CNN survey of working-class white Americans and from Pew Research to examine xenophobia in America in a time of Trump.
This policy insight examines the Hyde Amendment, an annually approved law that bans the use of federal funds to pay for abortions unless the pregnancy is a result of rape, incest, or endangerment of the life of a woman. The Hyde Amendment has become the focus of debate in the 2016 presidential election. Hillary Clinton is the first presidential candidate to openly support lifting the Hyde bans on federal funding for abortion, while Donald Trump recently endorsed the codification of the law and established a Pro-life coalition. This perspective details the federal programs that are affected by the Hyde Amendment, provides estimates on the share of women insured by Medicaid affected by the law, the impact on their access to abortion services, and the potential effect if the law were to be repealed or codified.
This policy insight examines the low rate of Medigap coverage among people under age 65 with disabilities on Medicare and the federal law that governs consumer rights and protections related to Medigap open enrollment.
In this Wall Street Journal Think Tank column, Drew Altman discusses what may be the most important change in the American health system—hint it’s not the Affordable Care Act—which has occurred without much discussion.
In this Wall Street Journal Think Tank column, Drew Altman discusses the risks of full disclosure of presidential candidates’ health records, and considers a possible solution to the problem.
In this Wall Street Journal Think Tank column, Drew Altman discusses the latest challenges faced by the Affordable Care Act (ACA) marketplaces and why they should be kept in perspective: “If Obamacare had bipartisan support, they would be treated much more like mundane implementation issues to be addressed by Congress than glaring headlines about Obamacare failure.”
In this Wall Street Journal Think Tank column, Drew Altman discusses why Donald Trump’s campaign trail claim that the Obama administration is withholding big Affordable Care Act premium increases until after the election to influence the outcome could not be true.